Expression of Cyclin�B1, D1 and K in Non‑small Cell Lung Cancer H1299 Cells Following Treatment With Sulforaphane

Oncology Reports - Greece
doi 10.3892/or.2018.6919
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Bioenergetics of Acquired Cisplatin Resistant H1299 Non-Small Cell Lung Cancer and P31 Mesothelioma Cells

Oncotarget
Oncology
2017English

The microRNA-200 Family Targets Multiple Non-Small Cell Lung Cancer Prognostic Markers in H1299 Cells and BEAS-2B Cells

International Journal of Oncology
Cancer ResearchOncology
2013English

Aberrant Expression of Cyclin D1 in Cancer

Signal Transduction Insights
2015English

Individualization of Treatment in Non-Small Cell Lung Cancer

F1000 Medicine Reports
2009English

Cyclin D1, Cancer Progression, and Opportunities in Cancer Treatment

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2016English

MA14.11 Factors Associated With Early Mortality in Non-Small Cell Lung Cancer Patients Following Systemic Anti-Cancer Treatment

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Cancer Stem Cells in Lung Cancer: Distinct Differences Between Small Cell and Non-Small Cell Lung Carcinomas

2011English

Inequalities in Non-Small Cell Lung Cancer Treatment and Mortality

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
2015English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy